Literature DB >> 31634479

A novel approach to study markers of dopamine signaling in peripheral immune cells.

Adithya Gopinath1, Andria Doty2, Phillip M Mackie1, Basil Hashimi1, Madison Francis1, Leila Saadatpour1, Kaustuv Saha1, Gerry Shaw1, Adolfo Ramirez-Zamora3, Michael S Okun3, Wolfgang J Streit1, Habibeh Khoshbouei4.   

Abstract

Human monocytes express known markers of dopamine synthesis, storage and clearance, including dopamine transporter (DAT), tyrosine hydroxylase (TH), all subtypes of dopamine receptors and vesicular monoamine transporter 2 (VMAT2). Immunohistochemical and immunofluorescent methodologies have traditionally been employed to determine DAT and TH expression in the CNS, their detection in the blood and specifically in the peripheral monocytes has not been studied by flow cytometry. Flow cytometry assays are widely used in medicine and in basic, preclinical or clinical research to quantify physical and chemical characteristics of target cell populations. Here, we have established a highly sensitive and reproducible flow cytometry panel to detect and quantify DAT and TH expression in freshly isolated or cryopreserved human peripheral monocytes. In healthy humans (n = 41 biological replicates), we show baseline DAT and TH expressing monocytes constitute ~12% of the peripheral blood mononuclear cell (PBMC) fraction when examined in fresh isolation from whole blood. Using an identical flow cytometry panel, we found that cryopreservation of PBMCs using multiple techniques resulted in altered PBMC populations as compared to fresh isolation and relative to one another. Among these, we identified an optimum cryopreservation method for detecting TH and DAT in cryopreserved PBMCs. Our data provide a sensitive and reproducible approach to examine dopamine signaling in peripheral human immune cells. This approach can be applied to study peripheral dopamine signaling under healthy and potentially under disease conditions. The use of dopamine signaling could also be explored as a technique to monitor therapeutic interventions particularly those targeting DAT and TH in the periphery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine transporter; Flow cytometry; Human monocytes; Peripheral blood mononuclear cell; Peripheral immune cells; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2019        PMID: 31634479      PMCID: PMC6939127          DOI: 10.1016/j.jim.2019.112686

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  23 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

2.  Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.

Authors:  Towfique Raj; Katie Rothamel; Sara Mostafavi; Chun Ye; Mark N Lee; Joseph M Replogle; Ting Feng; Michelle Lee; Natasha Asinovski; Irene Frohlich; Selina Imboywa; Alina Von Korff; Yukinori Okada; Nikolaos A Patsopoulos; Scott Davis; Cristin McCabe; Hyun-il Paik; Gyan P Srivastava; Soumya Raychaudhuri; David A Hafler; Daphne Koller; Aviv Regev; Nir Hacohen; Diane Mathis; Christophe Benoist; Barbara E Stranger; Philip L De Jager
Journal:  Science       Date:  2014-05-02       Impact factor: 47.728

3.  Three-step isolation of human blood monocytes using discontinuous density gradients of Percoll.

Authors:  A J Fluks
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  Immunochemical analysis of dopamine transporter protein in Parkinson's disease.

Authors:  G W Miller; J K Staley; C J Heilman; J T Perez; D C Mash; D B Rye; A I Levey
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

Review 5.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

6.  Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans.

Authors:  Patrick Autissier; Caroline Soulas; Tricia H Burdo; Kenneth C Williams
Journal:  Cytometry A       Date:  2010-05       Impact factor: 4.355

7.  Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs.

Authors:  Jacob Eriksen; Søren G F Rasmussen; Trine Nygaard Rasmussen; Christian Bjerggaard Vaegter; Joo Hwan Cha; Mu-Fa Zou; Amy Hauck Newman; Ulrik Gether
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

8.  Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous.

Authors:  Ratnadeep Mukherjee; Pijus Kanti Barman; Pravat Kumar Thatoi; Rina Tripathy; Bidyut Kumar Das; Balachandran Ravindran
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

Review 9.  Initial immunopathogenesis of multiple sclerosis: innate immune response.

Authors:  Norma Y Hernández-Pedro; Guillermo Espinosa-Ramirez; Verónica Pérez de la Cruz; Benjamín Pineda; Julio Sotelo
Journal:  Clin Dev Immunol       Date:  2013-09-24

10.  Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.

Authors:  Natasa Kustrimovic; Emanuela Rasini; Massimiliano Legnaro; Raffaella Bombelli; Iva Aleksic; Fabio Blandini; Cristoforo Comi; Marco Mauri; Brigida Minafra; Giulio Riboldazzi; Vanesa Sanchez-Guajardo; Franca Marino; Marco Cosentino
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

View more
  7 in total

1.  Psychostimulant-induced aberrant DNA methylation in an in vitro model of human peripheral blood mononuclear cells.

Authors:  Kaili Anier; Kelli Somelar; Külli Jaako; Margret Alttoa; Kerli Sikk; Raul Kokassaar; Kai Kisand; Anti Kalda
Journal:  Clin Epigenetics       Date:  2022-07-16       Impact factor: 7.259

2.  DAT and TH expression marks human Parkinson's disease in peripheral immune cells.

Authors:  Adithya Gopinath; Phillip Mackie; Basil Hashimi; Anna Marie Buchanan; Aidan R Smith; Rachel Bouchard; Gerry Shaw; Martin Badov; Leila Saadatpour; Aryn Gittis; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Parastoo Hashemi; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2022-06-07

3.  TNFα increases tyrosine hydroxylase expression in human monocytes.

Authors:  Adithya Gopinath; Martin Badov; Madison Francis; Gerry Shaw; Anthony Collins; Douglas R Miller; Carissa A Hansen; Phillip Mackie; Malú Gámez Tansey; Abeer Dagra; Irina Madorsky; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-07-20

Review 4.  Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.

Authors:  Michael J Beckstead; Rebecca D Howell
Journal:  Exp Neurol       Date:  2021-03-20       Impact factor: 5.620

5.  Functional characterization of the biogenic amine transporters on human macrophages.

Authors:  Phillip M Mackie; Adithya Gopinath; Dominic M Montas; Alyssa Nielsen; Aidan Smith; Rachel A Nolan; Kaitlyn Runner; Stephanie M Matt; John McNamee; Joshua E Riklan; Kengo Adachi; Andria Doty; Adolfo Ramirez-Zamora; Long Yan; Peter J Gaskill; Wolfgang J Streit; Michael S Okun; Habibeh Khoshbouei
Journal:  JCI Insight       Date:  2022-02-22

6.  Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts.

Authors:  Xiaochen Liu; Chunmeng Wang; Liping Pang; Liangliang Pan; Qi Zhang
Journal:  Cell Prolif       Date:  2022-04-11       Impact factor: 8.755

7.  Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine.

Authors:  J Daniel Obray; Christina A Small; Emily K Baldwin; Eun Young Jang; Jin Gyeom Lee; Chae Ha Yang; Jordan T Yorgason; Scott C Steffensen
Journal:  Front Cell Neurosci       Date:  2022-07-12       Impact factor: 6.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.